v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash $ 389 $ 357
Accounts receivable 14 9
Inventory, short term 219 336
Deferred expenses, short term 5
Net investment in leases, short term 102 101
Prepaid expenses and other current assets 322 325
Total current assets 1,051 1,128
Property and equipment, net 593 665
Right-to-use assets, net 487 705
Other assets:    
Inventory, long term 1,141
Net investment in leases, long term 43 120
Patents, net 293 307
Other assets 687 44
Total assets 3,154 4,110
Current liabilities:    
Accounts payable and accrued expenses, including $0 and $120 to related parties as of September 30, 2023 and December 31, 2022, respectively 3,470 2,852
Customer deposits 4
Deferred revenue, short term 5
Dividends payable 98 91
Lease liability, short term 339 313
Total current liabilities 3,911 3,261
Lease liability, long term 193 452
Total long-term liabilities 193 452
Total liabilities 4,104 3,713
Commitments and contingencies (Note 11)
Series C 9% Convertible Preferred Stock, $0.001 par value, $1,000 stated value, authorized 4,200 shares, 105 shares issued and outstanding; liquidation preference of $105 as of September 30, 2023 and December 31, 2022 105 105
(Deficit) Equity:    
Preferred stock, $0.001 par value, authorized 1,000,000 shares, designated 200 shares of Series A, 600 shares of Series B, 4,200 shares of Series C, 1,400 shares of Series D, 1,000 shares of Series E, 200,000 shares of Series F Preferred Stock. 105 shares of Series C outstanding as of September 30, 2023 and December 31, 2022 (see above)
Common stock, $0.001 par value, authorized 200,000,000 shares, 79,243,833 and 54,610,638 issued and outstanding as of September 30, 2023 and December 31, 2022, respectively 79 55
Additional paid in capital 237,727 216,232
Accumulated deficit (238,966) (215,974)
Total stockholders’ equity (deficit) attributable to BioSig Technologies, Inc. (1,160) 313
Non-controlling interest 105 (21)
Total (deficit) equity (1,055) 292
Total liabilities and (deficit) equity $ 3,154 $ 4,110

Source